Dr. Reddy's Laboratories Ltd ADR (RDY)
13.03 x 6 13.36 x 12
Post-market by (Cboe BZX)
13.22 +0.51 (+4.01%) 04/11/25 [NYSE]
13.03 x 6 13.36 x 12
Post-market 13.22 unch (unch) 16:04 ET
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RDY | TEVA | BBIO | ||
| Company | Dr. Reddy's Laboratories Ltd ADR | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 12.84 | 13.00 | 32.28 | ||
| High | 13.22 | 13.46 | 34.08 | ||
| Low | 12.78 | 12.88 | 31.90 | ||
| Last | 13.22 | 13.46 | 33.91 | ||
| Change | +0.51 | +0.64 | +1.60 | ||
| % Change | +4.01% | +4.99% | +4.95% | ||
| Volume | 2,756,700 | 12,225,200 | 2,149,700 | ||
| 20-Day Average Volume | 2,634,430 | 12,152,445 | 2,857,895 | ||
| Previous Close | 12.71 | 12.82 | 32.31 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.17 | 15.13 | 33.84 | ||
| 20-Day Raw Stochastic | 60.38% | 22.49% | 58.06% | ||
| 20-Day Relative Strength | 49.95% | 35.34% | 51.36% | ||
| Weighted Alpha | -12.02 | -25.83 | +30.75 | ||
| Today's Opinion | 88% Sell | 88% Sell | 88% Buy | ||
| Previous Opinion | 100% Sell | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Sell | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.96% since 04/04/25 | -2.46% since 04/04/25 | +8.10% since 04/04/25 | ||
| Low | 12.26 on 04/09/25 | 12.47 on 04/10/25 | 28.33 on 04/09/25 | ||
| High | 13.22 on 04/11/25 | 14.55 on 04/07/25 | 34.08 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | +4.01% since 03/11/25 | -16.40% since 03/11/25 | +4.85% since 03/11/25 | ||
| Low | 12.26 on 04/09/25 | 12.47 on 04/10/25 | 28.33 on 04/09/25 | ||
| High | 13.85 on 03/24/25 | 16.92 on 03/13/25 | 37.94 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | -14.27% since 01/10/25 | -35.72% since 01/10/25 | +16.61% since 01/10/25 | ||
| Low | 12.26 on 04/09/25 | 12.47 on 04/10/25 | 28.10 on 01/13/25 | ||
| High | 15.35 on 01/14/25 | 22.40 on 01/28/25 | 39.47 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | -15.53% since 10/11/24 | -21.97% since 10/11/24 | +30.93% since 10/11/24 | ||
| Low | 12.26 on 04/09/25 | 12.47 on 04/10/25 | 21.72 on 11/19/24 | ||
| High | 16.04 on 12/27/24 | 22.80 on 12/27/24 | 39.47 on 02/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,035,686 | 15,261,472 | 6,449,309 | ||
| Shares Outstanding, K | 834,772 | 1,133,839 | 190,189 | ||
| Annual Sales | 3,350,000,000 | 16,544,000,000 | 221,900,000 | ||
| Annual Net Income | 668,000,000 | -1,639,000,000 | -535,760,000 | ||
| Last Quarter Sales | 986,310,000 | 4,229,000,000 | 5,880,000 | ||
| Last Quarter Net Income | 166,770,000 | -218,000,000 | -265,050,000 | ||
| 60-Month Beta | 0.51 | 0.72 | 1.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 01/23/25 | 0.71 on 01/29/25 | -1.31 on 02/20/25 | ||
| Latest Earnings Date | 05/06/25 | 05/07/25 | 05/01/25 | ||
| Most Recent Dividend | 0.404 on 07/30/24 | 0.072 on 11/27/17 | N/A | ||
| Next Ex-Dividends Date | 07/30/24 | 11/27/17 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.24 | 5.32 | 0.00 | ||